Cargando…

Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes

The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Murley, Alexander G, Coyle-Gilchrist, Ian, Rouse, Matthew A, Jones, P Simon, Li, Win, Wiggins, Julie, Lansdall, Claire, Rodríguez, Patricia Vázquez, Wilcox, Alicia, Tsvetanov, Kamen A, Patterson, Karalyn, Lambon Ralph, Matthew A, Rowe, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241953/
https://www.ncbi.nlm.nih.gov/pubmed/32438414
http://dx.doi.org/10.1093/brain/awaa097
_version_ 1783537149074735104
author Murley, Alexander G
Coyle-Gilchrist, Ian
Rouse, Matthew A
Jones, P Simon
Li, Win
Wiggins, Julie
Lansdall, Claire
Rodríguez, Patricia Vázquez
Wilcox, Alicia
Tsvetanov, Kamen A
Patterson, Karalyn
Lambon Ralph, Matthew A
Rowe, James B
author_facet Murley, Alexander G
Coyle-Gilchrist, Ian
Rouse, Matthew A
Jones, P Simon
Li, Win
Wiggins, Julie
Lansdall, Claire
Rodríguez, Patricia Vázquez
Wilcox, Alicia
Tsvetanov, Kamen A
Patterson, Karalyn
Lambon Ralph, Matthew A
Rowe, James B
author_sort Murley, Alexander G
collection PubMed
description The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic approach to clinical phenotype and brain morphometry. In a cross-sectional epidemiological study, we examined 310 patients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural variant frontotemporal dementia, non-fluent, and semantic variants of primary progressive aphasia (PPA), progressive supranuclear palsy and corticobasal syndrome. We included patients with logopenic PPA and those who met criteria for PPA but not a specific subtype. To date, 49 patients have a neuropathological diagnosis. A principal component analysis identified symptom dimensions that broadly recapitulated the core features of the main clinical syndromes. However, the subject-specific scores on these dimensions showed considerable overlap across the diagnostic groups. Sixty-two per cent of participants had phenotypic features that met the diagnostic criteria for more than one syndrome. Behavioural disturbance was prevalent in all groups. Forty-four per cent of patients with corticobasal syndrome had progressive supranuclear palsy-like features and 30% of patients with progressive supranuclear palsy had corticobasal syndrome-like features. Many patients with progressive supranuclear palsy and corticobasal syndrome had language impairments consistent with non-fluent variant PPA while patients with behavioural variant frontotemporal dementia often had semantic impairments. Using multivariate source-based morphometry on a subset of patients (n = 133), we identified patterns of covarying brain atrophy that were represented across the diagnostic groups. Canonical correlation analysis of clinical and imaging components found three key brain-behaviour relationships, with a continuous spectrum across the cohort rather than discrete diagnostic entities. In the 46 patients with follow-up (mean 3.6 years) syndromic overlap increased with time. Together, these results show that syndromes associated with frontotemporal lobar degeneration do not form discrete mutually exclusive categories from their clinical features or structural brain changes, but instead exist in a multidimensional spectrum. Patients often manifest diagnostic features of multiple disorders while deficits in behaviour, movement and language domains are not confined to specific diagnostic groups. It is important to recognize individual differences in clinical phenotype, both for clinical management and to understand pathogenic mechanisms. We suggest that a transdiagnostic approach to the spectrum of frontotemporal lobar degeneration syndromes provides a useful framework with which to understand disease aetiology, progression, and heterogeneity and to target future treatments to a higher proportion of patients.
format Online
Article
Text
id pubmed-7241953
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72419532020-05-26 Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes Murley, Alexander G Coyle-Gilchrist, Ian Rouse, Matthew A Jones, P Simon Li, Win Wiggins, Julie Lansdall, Claire Rodríguez, Patricia Vázquez Wilcox, Alicia Tsvetanov, Kamen A Patterson, Karalyn Lambon Ralph, Matthew A Rowe, James B Brain Original Articles The syndromes caused by frontotemporal lobar degeneration have highly heterogeneous and overlapping clinical features. There has been great progress in the refinement of clinical diagnostic criteria in the past decade, but we propose that a better understanding of aetiology, pathophysiology and symptomatic treatments can arise from a transdiagnostic approach to clinical phenotype and brain morphometry. In a cross-sectional epidemiological study, we examined 310 patients with a syndrome likely to be caused by frontotemporal lobar degeneration, including behavioural variant frontotemporal dementia, non-fluent, and semantic variants of primary progressive aphasia (PPA), progressive supranuclear palsy and corticobasal syndrome. We included patients with logopenic PPA and those who met criteria for PPA but not a specific subtype. To date, 49 patients have a neuropathological diagnosis. A principal component analysis identified symptom dimensions that broadly recapitulated the core features of the main clinical syndromes. However, the subject-specific scores on these dimensions showed considerable overlap across the diagnostic groups. Sixty-two per cent of participants had phenotypic features that met the diagnostic criteria for more than one syndrome. Behavioural disturbance was prevalent in all groups. Forty-four per cent of patients with corticobasal syndrome had progressive supranuclear palsy-like features and 30% of patients with progressive supranuclear palsy had corticobasal syndrome-like features. Many patients with progressive supranuclear palsy and corticobasal syndrome had language impairments consistent with non-fluent variant PPA while patients with behavioural variant frontotemporal dementia often had semantic impairments. Using multivariate source-based morphometry on a subset of patients (n = 133), we identified patterns of covarying brain atrophy that were represented across the diagnostic groups. Canonical correlation analysis of clinical and imaging components found three key brain-behaviour relationships, with a continuous spectrum across the cohort rather than discrete diagnostic entities. In the 46 patients with follow-up (mean 3.6 years) syndromic overlap increased with time. Together, these results show that syndromes associated with frontotemporal lobar degeneration do not form discrete mutually exclusive categories from their clinical features or structural brain changes, but instead exist in a multidimensional spectrum. Patients often manifest diagnostic features of multiple disorders while deficits in behaviour, movement and language domains are not confined to specific diagnostic groups. It is important to recognize individual differences in clinical phenotype, both for clinical management and to understand pathogenic mechanisms. We suggest that a transdiagnostic approach to the spectrum of frontotemporal lobar degeneration syndromes provides a useful framework with which to understand disease aetiology, progression, and heterogeneity and to target future treatments to a higher proportion of patients. Oxford University Press 2020-05 /pmc/articles/PMC7241953/ /pubmed/32438414 http://dx.doi.org/10.1093/brain/awaa097 Text en © The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Murley, Alexander G
Coyle-Gilchrist, Ian
Rouse, Matthew A
Jones, P Simon
Li, Win
Wiggins, Julie
Lansdall, Claire
Rodríguez, Patricia Vázquez
Wilcox, Alicia
Tsvetanov, Kamen A
Patterson, Karalyn
Lambon Ralph, Matthew A
Rowe, James B
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title_full Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title_fullStr Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title_full_unstemmed Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title_short Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
title_sort redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241953/
https://www.ncbi.nlm.nih.gov/pubmed/32438414
http://dx.doi.org/10.1093/brain/awaa097
work_keys_str_mv AT murleyalexanderg redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT coylegilchristian redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT rousematthewa redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT jonespsimon redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT liwin redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT wigginsjulie redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT lansdallclaire redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT rodriguezpatriciavazquez redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT wilcoxalicia redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT tsvetanovkamena redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT pattersonkaralyn redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT lambonralphmatthewa redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes
AT rowejamesb redefiningthemultidimensionalclinicalphenotypesoffrontotemporallobardegenerationsyndromes